Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients ? results from real-life prospective study

被引：5
|
作者：
Hornak, Tomas [1 ,2 ]
Semerad, Lukas [1 ,2 ]
Zackova, Daniela [1 ,2 ]
Weinbergerova, Barbora [1 ,2 ]
Sustkova, Zuzana [1 ,2 ]
Prochazkova, Jirina [1 ,2 ]
Belohlavkova, Petra [3 ,4 ]
Stejskal, Lukas [5 ]
Rohon, Peter [6 ]
Faber, Edgar [6 ]
Zak, Pavel [3 ,4 ]
Mayer, Jiri [1 ,2 ]
Racil, Zdenek [1 ,2 ]
机构：
[1] Masaryk Univ, Dept Internal Med Hematol & Oncol, Jihlavska 20, Brno 62500, Czech Republic
[2] Univ Hosp Brno, Brno, Czech Republic
[3] Charles Univ Fac Hosp, Dept Internal Med Hematol 4, Hradec Kralove, Czech Republic
[4] Fac Med, Hradec Kralove, Czech Republic
[5] Univ Hosp Ostrava, Dept Hematooncol, Ostrava, Czech Republic
[6] Univ Hosp Olomouc, Dept Hematooncol, Olomouc, Czech Republic
来源：
LEUKEMIA & LYMPHOMA | 2020年 / 61卷 / 02期
关键词：
D O I：
10.1080/10428194.2019.1672054
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：494 / 496
页数：3
相关论文
共 6 条
  • [1] Selective Escalation of Imatinib Therapy and Early Switching to Nilotinib In De Novo Chronic Phase CML Patients: Interim Results From the TIDEL-II Trial
    Yeung, David T.
    Osborn, Michael
    White, Deborah L.
    Branford, Susan
    Haswell, Lauren
    Slader, Cassandra
    Issa, Samar
    Hiwase, Devendra K.
    Hertzberg, Mark S.
    Schwarer, Anthony P.
    Filshie, Robin
    Arthur, Christopher K.
    Kwan, Yiu Lam
    Forsyth, Cecily J.
    Ross, David M.
    Mills, Anthony K.
    Grigg, Andrew
    Hughes, Timothy
    BLOOD, 2010, 116 (21) : 96 - 96
  • [2] Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience
    Zilioli, Vittorio Ruggero
    Cencini, Emanuele
    De Lorenzo, Sonya
    Pezzullo, Luca
    Merli, Michele
    Rivellini, Flavia
    Muzi, Cristina
    Emiliano, Barbieri
    Marcheselli, Luigi
    Luminari, Stefano
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (03)
  • [3] Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience (vol 42, e3273, 2023)
    Zilioli, Vittorio Ruggero
    Cencini, Emanuele
    De Lorenzo, Sonya
    Pezzullo, Luca
    Merli, Michele
    Rivellini, Flavia
    Muzi, Cristina
    Emiliano, Barbieri
    Marcheselli, Luigi
    Luminari, Stefano
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (04)
  • [4] The Dose and the duration of frontline therapy with Imatinib does not affect response to Dasatinib in Imatinib-Resistant or -intolerant patients with chronic myeloid leukemia (CML). Results from a real Life-Based Italian Multicenter retrospective study on 124 Patients.
    Visani, Giuseppe
    Breccia, Massimo
    Piccaluga, Pier Paolo
    Gozzini, Antonella
    Specchia, Giorgina
    Montefusco, Enrico
    Morra, Enrica
    Annunziata, Mario
    Luciano, Luigiana
    Camera, Andrea
    Cavazzini, Francesco
    Stagno, Fabio
    Di Raimondo, Francesco
    Pregno, Patrizia
    Pirillo, Francesca
    Santini, Valeria
    Bosi, Alberto
    Pacilli, Matteo
    Pungolino, Ester
    Usala, Emilio
    Angelucci, Emanuele
    Crugnola, Monica
    Binotto, Gianni
    Maino, Elena
    Loscocco, Federica
    Barulli, Sara
    Nicolini, Giuseppina
    Cuneo, Antonio
    Latagliata, Roberto
    Ferrara, Felicetto
    Isidori, Alessandro
    BLOOD, 2009, 114 (22) : 461 - 461
  • [5] LOW DOSE CONTINUOUS THERAPY WITH DASATINIB SIGNIFICANTLY IMPACT ON SURVIVAL OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML) RESISTANT OR INTOLERANT TO IMATINIB. RESULTS FROM A REAL LIFE-BASED ITALIAN MULTICENTER RETROSPECTIVE STUDY ON 114 UNSELECTED PATIENTS
    Visani, G.
    Breccia, M.
    Gozzini, A.
    Specchia, G.
    Montefusco, E.
    Morra, E.
    Annunziata, M.
    Luciano, L.
    Camera, A.
    Cavazzini, F.
    Stagno, F.
    Di Raimondo, F.
    Pregno, P.
    Santini, V.
    Piccaluga, P.
    Pacilli, M.
    Pungolino, E.
    Usala, E.
    Angelucci, E.
    Cuneo, A.
    Ferrara, F.
    Crugnola, M.
    Binotto, G.
    Maino, E.
    Latagliata, R.
    Nicolini, G.
    Barulli, S.
    Loscocco, F.
    Alimena, G.
    Isidori, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 345 - 345
  • [6] The routine real-life use of trabectedin (T) in patients with advanced soft tissue sarcoma (STS) across Europe: An analysis of overall vs. per country results from Y-IMAGE study
    Penel, N.
    Benson, C.
    Kasper, B.
    Buonadonna, A.
    ANNALS OF ONCOLOGY, 2017, 28
1